Skip to main content

UPDATE: InformedDNA, Edimer Collaborate on Genetic Counseling Program for XLHED

The story has been corrected to state that InformedDNA is a genetics services firm, not a genetics testing company.

NEW YORK (GenomeWeb) – Genetic services firm InformedDNA today announced it is developing a genetic counseling program as part of a collaboration with Edimer Pharmaceuticals in support of the drug firm's clinical program directed at X-linked hypohidrotic ectodermal dysplasia (XLHED).

The genetic counseling program will provide services to patients with the rare genetic disorder and their families, help identify patients with XLHED, and support Edimer's clinical efforts, which include the development of EDI200, an ectodysplasin-A1 replacement protein now in phase 2 clinical trials.

As part of the counseling program, InformedDNA will educate the community on XLHED, provide patients with risk assessments based on family history, review the mode of inheritance and implications for family members, discuss genetic testing options, highlight the importance of early diagnosis and potential treatments, and discuss current clinical trials, the St. Petersburg, Fl.-based company said.

XLHED is caused by a change in the gene EDA and is characterized by symptoms that include the lack of sweat glands, poor temperature regulation, respiratory problems, and hair and tooth malformations. No treatments for the condition are currently commercially available.

"This collaboration with InformedDNA is uniquely supporting Edimer's research goals for EDI200," Edimer President and CEO Neil Kirby said in a statement. "In growing the body of genetic data available on XLHED, we can better serve the population of patients and families impacted by this rare genetic disease."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.